CLINICAL_TRIALS trial_result · 2016-11-11

Clinical Trial Update: Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects. [Phase 1]

Phase 1 study of PF-06743649 in gout patients was terminated; results evaluating efficacy, safety, and tolerability were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pfizer | Conditions: Gout | Phase 1 | Status: TERMINATED | Results posted: 2016-11-11